CBD may look like a distinctly modern product, complete with droppers, softgels, laboratory reports, and very tidy labels. Its story, however, begins long before anyone knew what a cannabinoid was.

For thousands of years, people cultivated Cannabis sativa for fiber, seed, food, ritual, and traditional preparations. Hemp later supplied rope, sailcloth, paper, and other practical materials. CBD entered the story much more recently, after scientists learned to isolate individual compounds and investigate how they interact with biological systems.

That distinction matters. The history of hemp is not identical to the history of medicinal cannabis, and neither is identical to the history of CBD. This timeline connects the three without treating every ancient cannabis reference as proof of a modern CBD claim.

First, What Is the Difference Between Hemp, Cannabis, and CBD?

Cannabis is a plant genus. Hemp is a legal and agricultural category applied to cannabis that meets a defined delta-9 THC threshold. Under current United States federal law, hemp generally means cannabis and its derivatives containing no more than 0.3 percent delta-9 THC by dry weight.

CBD, or cannabidiol, is one of many compounds produced by the cannabis plant. It is not the plant itself. CBD can be derived from legally defined hemp, but that does not mean every CBD product is automatically lawful for every use, FDA-approved, accurately labeled, or free of THC.

Ancient Hemp: Fiber, Seed, and Everyday Utility

Some of the earliest records of hemp cultivation come from Asia, particularly China. Archaeological and written evidence indicates that cannabis plants were valued for strong fibers and useful seeds. Over time, cultivation spread through parts of Asia, the Middle East, and Europe.

Hemp's long stalks could be processed into fiber for rope, textiles, nets, and other goods. Seeds could be eaten or pressed for oil. These practical roles are central to hemp history and require no modern wellness language to make them impressive. A plant that could help clothe people, rig ships, and supply food ingredients already had a fairly full résumé.

Historical texts also describe cannabis in traditional preparations and rituals. Translating those records into modern medical terms is difficult. Ancient plant varieties, preparation methods, doses, and cultural meanings were not standardized, and historical words do not always map neatly onto today's cannabis chemistry.

Women in Early Cannabis History

Women remain an important part of this longer history. Some ancient and early medical writings connect cannabis preparations with menstruation, childbirth, and other aspects of reproductive care. Archaeological discoveries have also found cannabis material in burial and ritual settings that included women.

These records tell us that women participated in the plant's social and medical history. They do not establish that a preparation was safe, effective, or equivalent to CBD. Ancient cannabis may have contained different mixtures of cannabinoids, and claims about a specific person or purpose are sometimes based on interpretation rather than direct evidence.

Pregnancy and breastfeeding deserve particular caution. Historical use is not a safety study, and the FDA advises against using CBD, THC, or marijuana in any form during pregnancy or while breastfeeding.

Hemp Crosses Continents

By the 16th century, hemp was widely cultivated in parts of Europe for fiber. European colonists later brought the crop to the Americas. A USDA historical report notes cultivation in Chile in the 1500s and New England in the 1600s, followed by production in Virginia and Kentucky.

In the United States, hemp became associated with cordage and sailcloth. Kentucky, Missouri, and Illinois developed notable production during the 19th century. Demand later declined as cotton, jute, abaca, changing shipping technology, international trade, and regulation reshaped the market.

This period helps explain why hemp appears in historical discussions of farming, naval supply, and manufacturing more often than CBD. Farmers were growing a fiber crop, not filling bottles with isolated cannabidiol.

Cannabis Enters 19th-Century Western Medicine

During the 1800s, physicians and pharmacists in Europe and North America began writing about cannabis preparations informed partly by practices observed in South Asia. Cannabis extracts appeared in medical literature and formularies, but their chemical composition was not understood or consistently controlled.

Historical accounts include cannabis preparations used in obstetrics and gynecology. The story that Queen Victoria used cannabis for menstrual discomfort is repeated frequently, often alongside comments by her physician, Sir John Russell Reynolds. Reynolds did write favorably about cannabis in selected medical contexts, but direct evidence documenting the Queen's personal use is limited. It is more accurate to call it a popular historical claim than a confirmed event.

Older medical endorsements should also be read in their own context. Nineteenth-century medicine used many substances and standards that would not satisfy modern clinical, manufacturing, or safety requirements. A physician's observation from 1890 is historically interesting, not a substitute for a controlled trial.

Restriction Changes the American Hemp Industry

Federal policy increasingly restricted cannabis during the 20th century. The Marihuana Tax Act of 1937 imposed registration, taxation, and administrative controls that affected cannabis cultivation, including industrial hemp.

World War II briefly changed the calculation. When imported fiber supplies became difficult to obtain, the federal government supported domestic hemp production. The USDA promoted the crop, and production peaked during the war years. Afterward, imported fibers returned, federal restrictions resumed, and domestic production declined.

The Controlled Substances Act of 1970 then placed marijuana within a strict federal framework. For decades, hemp and high-THC cannabis were often treated together under federal controls, even though they could serve very different agricultural and commercial purposes.

CBD Emerges From 20th-Century Chemistry

The modern history of CBD began when researchers separated cannabis into identifiable chemical compounds. CBD was first isolated in the 1940s. Subsequent work clarified its structure, while later research identified THC and explored how cannabinoids act in the body.

Scientific interest expanded with the discovery of cannabinoid receptors and naturally occurring signaling molecules called endocannabinoids. Together with related enzymes, these components became known as the endocannabinoid system.

The discovery of this system did not prove every claim made about CBD. It gave researchers a framework for asking better questions about cannabinoids, receptors, signaling, metabolism, and possible clinical applications. That difference between a plausible mechanism and a demonstrated benefit remains essential today.

Women Helping Shape Modern Cannabinoid Research

Women have made substantial contributions to the field's modern scientific chapter. Their work spans molecular biology, pharmacology, neuroscience, lipid signaling, reproductive physiology, stress research, and clinical investigation.

• Cristina Sánchez, PhD, at Complutense University of Madrid, has investigated cannabinoid signaling and cancer biology in laboratory models. This work explores possible mechanisms and research targets, but it should not be translated into a claim that consumer CBD products treat cancer.
• Cecilia J. Hillard, PhD, at the Medical College of Wisconsin, has studied cannabinoid pharmacology, endocannabinoid biochemistry, brain function, and biological responses to stress.
• Heather Bradshaw, PhD, at Indiana University, has contributed to research on endocannabinoids and other signaling lipids, including their biosynthesis, metabolism, and communication within the body.
• Saoirse O'Sullivan, PhD, has published research on cannabinoid pharmacology and participated in human cannabinoid studies, helping connect laboratory questions with clinical investigation.

Their contributions are best honored by describing the science accurately. Cell studies, animal models, observational research, and clinical trials answer different questions. Early-stage findings should not be presented as established treatments.

The Return of Legal Hemp in the United States

Federal hemp policy began changing in stages. The 2014 Farm Bill permitted certain state departments of agriculture and institutions of higher education to grow hemp under research programs. The 2018 Farm Bill went further by removing hemp, as federally defined, from the Controlled Substances Act and creating a framework for regulated production.

That change accelerated hemp cultivation and the commercial CBD market. It did not place every hemp-derived product outside all federal regulation. The FDA retained authority over foods, dietary supplements, drugs, cosmetics, animal products, labeling, and health claims within its jurisdiction.

State laws can also differ. A product's origin from hemp does not automatically answer whether it may be manufactured, sold, shipped, advertised, or used in a particular way.

2018: A Milestone for Prescription Cannabidiol

In June 2018, the FDA approved Epidiolex, a prescription oral solution containing cannabidiol, for seizures associated with two rare epilepsy syndromes. Its approved uses have since evolved through formal regulatory review.

This was an important moment in CBD history because it showed that a purified cannabinoid could be evaluated through the drug-approval process. It did not amount to FDA approval of retail CBD oils, gummies, salves, powders, or general wellness claims.

A standardized prescription drug also cannot be treated as interchangeable with an over-the-counter product. Formulation, concentration, manufacturing controls, dosing, medical supervision, and supporting evidence all matter.

CBD Today: More Products, More Questions

Today's CBD market includes isolate, broad-spectrum, and full-spectrum extracts in oils, capsules, topicals, foods, and other formats. The variety is much greater than the evidence available for many advertised uses.

Modern consumers have tools that earlier generations did not, including batch-specific Certificates of Analysis. A COA may show cannabinoid concentrations and reported contaminant results for a tested sample. It does not prove that a product provides a health benefit, but it can help a shopper evaluate whether the contents align with the label.

Responsible CBD education should distinguish among:

• Historical or traditional use
• Laboratory and animal research
• Observational human research
• Controlled clinical trials
• FDA-approved uses of a specific prescription drug
• Unapproved claims made for consumer products

Those categories can coexist without being collapsed into one sweeping promise.

A Short Hemp and CBD Timeline

Frequently Asked Questions

Is hemp the same as CBD?

No. Hemp is a plant and legal crop category. CBD is one compound that may be extracted from hemp.

Did ancient people use CBD?

Ancient people used cannabis plants and preparations, but they did not isolate, measure, or describe CBD as a distinct compound. It is inaccurate to label every historical cannabis use as CBD use.

Did Queen Victoria use cannabis?

The claim is widely repeated, and her physician wrote about cannabis in medicine. Direct documentation proving that he prescribed it to Queen Victoria is limited, so the story should be presented as uncertain.

Was hemp always legal in the United States?

No. Its treatment changed across different federal laws and programs. The 2018 Farm Bill created the present federal framework for hemp, while states and federal agencies retain additional authority.

Does historical use prove that CBD works?

No. Traditional use can guide research questions, but it does not establish the safety or effectiveness of a modern product. Reliable health conclusions require appropriate human evidence.

Has the FDA approved CBD?

The FDA has approved a specific prescription cannabidiol drug for certain seizure disorders. That approval does not apply to ordinary retail CBD products or unrelated health claims.

The Bottom Line

Hemp's history stretches from ancient fiber and seed cultivation to wartime agriculture, modern farming, and a diverse consumer market. CBD's history is shorter and rooted in 20th-century chemistry, endocannabinoid research, clinical investigation, and changing regulation.

Women appear throughout that story, from historical records of cannabis preparations to influential roles in modern cannabinoid science. Recognizing those contributions does not require exaggerating what the research proves. The most respectful history is one that preserves both the people and the scientific context.

Sources and Further Reading

• USDA Economic Research Service: Industrial Hemp in the United States, History and Market Potential
• U.S. Department of Agriculture: Hemp
• USDA: 2018 Farm Bill Hemp Executive Summary and Legal Opinion
• PubMed: History of Cannabis and the Endocannabinoid System
• FDA: 2018 Cannabidiol Prescription Drug Approval Package
• FDA: What You Need to Know About Products Containing Cannabis or Cannabis-Derived Compounds
• Complutense University of Madrid: Cristina Sánchez García
• Medical College of Wisconsin: Cecilia J. Hillard, PhD
• Indiana University: Heather Bradshaw, PhD

FDA Disclosure: The statements in this article have not been evaluated by the Food and Drug Administration. Products discussed are not intended to diagnose, treat, cure, or prevent any disease or medical condition. This article is for general educational purposes and is not medical advice. Consult a licensed healthcare professional before using CBD or another cannabinoid product.